Study guide
Primary Immunodeficiencies, Warning Signs, Live Vaccine Contraindications, and European Immunisation Schedules
EBP-EAP Examination in Paediatrics Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Governance, Ethics & Child Safeguarding
EBP-EAP Format, Delivery, Scoring, and Clinical Vignette Strategy Paediatric Ethics, Consent/Assent, Gillick Competence, and Patient Safety Child Protection, Physical/Emotional Abuse, Neglect, and Non-Accidental Injury (NAI)
2 Chapter 2: Neonatal Transition, Resuscitation & Prematurity
Delivery Room Care, Apgar Scoring, and Neonatal Resuscitation Algorithm Respiratory Distress Syndrome (RDS), Surfactant Therapy, and Bronchopulmonary Dysplasia Perinatal Asphyxia, HIE Sarnat Staging, and Therapeutic Hypothermia Protocol
3 Chapter 3: Neonatal Morbidities, Jaundice & Congenital Infections
Unconjugated vs Conjugated Hyperbilirubinemia, Phototherapy Thresholds, and Exchange Transfusion Early- vs Late-Onset Sepsis, Group B Streptococcus, and Congenital TORCH Infections NEC Diagnosis/Bell Staging, Neonatal Hypoglycaemia, and Newborn Bloodspot Screening
4 Chapter 4: Acute Paediatric Emergencies & Critical Care
EPLS/PALS Structured Approach, Types of Shock, and Weight-Based Fluid Boluses Clinical Diagnostic Criteria, Intramuscular Adrenaline Dosing, and Refractory Anaphylaxis 5-Minute Time-Critical Anticonvulsant Protocol and Status Epilepticus Care Common Toxidromes (Paracetamol, Iron, Caustics, Button Batteries) and Decontamination
5 Chapter 5: Paediatric Respiratory Medicine
Stridor Differential, Croup (Westley Score & Dexamethasone), and Epiglottitis RSV Pathogenesis, Supportive Management, Oxygen/High-Flow Criteria, and Futility of Bronchodilators/Steroids European/BTS Guidelines on Chronic Stepwise Control and Acute Severe Exacerbation Management Community-Acquired Pneumonia Etiology, Parapneumonic Effusion/Empyema, and Cystic Fibrosis Pulmonary Exacerbations
6 Chapter 6: Paediatric Cardiology
Acyanotic vs Cyanotic Congenital Heart Disease: Ductal Patency, Shunt Lesions, and Emergency Stabilization Paediatric Murmurs and Arrhythmias: Innocent vs Pathological Murmurs, SVT, and Resuscitation Protocols Acquired Heart Disease: Kawasaki Disease, Coronary Aneurysm Prevention, and Acute Rheumatic Fever
7 Chapter 7: Paediatric Gastroenterology, Hepatology & Nutrition
Dehydration Severity Assessment, Oral Rehydration Therapy (ORT), and Intravenous Fluid Protocols ESPGHAN Coeliac Diagnostic Criteria (Biopsy-Sparing Pathway) and Paediatric Crohn's/Ulcerative Colitis Breastfeeding, Formula Selection, Cow's Milk Protein Allergy (CMPA), GERD vs GOR, and Faltering Growth Prolonged Neonatal Jaundice Workup, Biliary Atresia Red Flags, and Acute Hepatitis/Liver Failure
8 Chapter 8: Paediatric Nephrology, Fluids & Electrolyte Balance
Paediatric UTI Diagnosis, Imaging Criteria (Ultrasound/DMSA/MCUG), and Vesicoureteral Reflux Minimal Change Nephrotic Syndrome (Steroid Regimen & Complications) vs Acute Post-Infectious Glomerulonephritis Paediatric AKI (pRIFLE/KDIGO), Haemolytic Uraemic Syndrome (HUS), and Hyperkalaemia/Dysnatraemia Management
9 Chapter 9: Paediatric Endocrinology & Inborn Errors of Metabolism
Paediatric DKA Protocol (ISPAD/European Fluid & Insulin Guidelines, Cerebral Oedema Prevention) and T1DM Maintenance Congenital Hypothyroidism Screening & Levothyroxine, Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency), and Adrenal Crisis Short Stature Workup, Precocious vs Delayed Puberty, and Approach to Suspected Inborn Errors of Metabolism (IEM)
10 Chapter 10: Paediatric Neurology, Neurodevelopment & Mental Health
Simple vs Complex Febrile Seizures, Childhood Epilepsy Syndromes (Absence, Infantile Spasms, Benign Rolandic), and Antiseizure Medications Red Flags for Raised Intracranial Pressure (ICP), Brain Tumours, Migraine vs Tension Headache Acute Bacterial Meningitis (LP Contraindications, Ceftriaxone, Dexamethasone) and Viral Encephalitis (Aciclovir) Developmental Milestones (Gross Motor, Fine Motor/Vision, Speech/Language, Social), Autism Spectrum, ADHD, and Cerebral Palsy
11 Chapter 11: Paediatric Haematology & Oncology
Microcytic Anaemia (Iron Deficiency vs Thalassaemia Trait/Mentzer Index), Haemolytic Anaemias (Spherocytosis, G6PD) Sickle Cell Crises (Vaso-occlusive, Acute Chest Syndrome, Stroke Prevention), Immune Thrombocytopenia (ITP), and Haemophilia A/B Acute Lymphoblastic Leukaemia (ALL), Neuroblastoma, Wilms Tumour, and Management of Febrile Neutropenia
12 Chapter 12: Paediatric Infectious Diseases, Immunology & Allergy
Common Childhood Exanthems: Clinical Morphology, Timelines, Complications, and Management Paediatric Tuberculosis, Sepsis Six in Children, and Acute Osteoarticular Infections Pediatric Allergy, Atopic Eczema, Food Hypersensitivity, and Desensitization Primary Immunodeficiencies, Warning Signs, Live Vaccine Contraindications, and European Immunisation Schedules
13 Chapter 13: Paediatric Musculoskeletal, Dermatology & Surgical Conditions
The Limping Child, Septic Arthritis vs Transient Synovitis, and Juvenile Idiopathic Arthritis Henoch-Schönlein Purpura, Kawasaki Disease vs MIS-C, Infantile Haemangiomas, and Common Pediatric Eruptions Acute Appendicitis, Intussusception, Pyloric Stenosis, Testicular Torsion, and Incarcerated Hernia
14 Chapter 14: Research Methods, Biostatistics & Evidence-Based Paediatrics
Study Designs, Causality, Bias, and Epidemiological Measures in Paediatrics Diagnostic Test Accuracy, Statistical Inference, and Hypothesis Testing Systematic Reviews, Meta-Analysis, Decision Analysis, and Paediatric Research Ethics
15 Chapter 15: Paediatric Ophthalmology & ENT Disorders
Paediatric Vision Assessment, Refractive Disorders, Strabismus, and Leukocoria Ocular Emergencies, Orbital Infections, ROP, and Systemic Manifestations Paediatric Otolaryngology: Otitis Media, Hearing Impairment, and Upper Airway Conditions
16 Chapter 16: Paediatric Sports Medicine & Musculoskeletal Health
Skeletal Maturity, Physeal Injuries, Apophysitis, and Overuse Syndromes Paediatric Sports Concussion, Second Impact Syndrome, and Return-to-Play Protocols Pre-Participation Screening, Physical Activity Guidelines, and Chronic Disease Clearance
17 Chapter 17: Adolescent Medicine & Healthcare Transition
Biopsychosocial Development, Pubertal Staging, and Adolescent Communication Adolescent Confidentiality, Risk Behaviours, Reproductive Health, and Eating Disorders Chronic Illness in Adolescence and Structured Healthcare Transition
18 Chapter 18: Paediatric Genetics, Dysmorphology & Clinical Genomics
Patterns of Inheritance, Non-Mendelian Mechanisms, and Pedigree Construction Clinical Dysmorphology, Chromosomal Aneuploidies, and Microdeletion Syndromes Genetic Testing Technologies, Prenatal Diagnosis, and Genetic Counselling Ethics
19 Chapter 19: Paediatric Mental Health, Behaviour & Community Medicine
Cognitive Development, Attachment, Screening, and Common Emotional Disorders Regulatory Disorders, Neurodevelopmental Behavioural Conditions, and Psychosomatic Illness Community Child Healthcare Structures, Disability Coordination, and Child Advocacy
Primary Immunodeficiencies, Warning Signs, Live Vaccine Contraindications, and European Immunisation Schedules
Key Takeaways Explain This Topic AI
The Jeffrey Modell Foundation 10 warning signs provide a crucial clinical framework for the early identification of Inborn Errors of Immunity (primary immunodeficiencies), highlighting recurrent serious bacterial infections, refractory thrush, deep abscesses, failure to thrive, and the persistent need for intravenous antibiotics.
B-cell and humoral antibody deficiencies constitute over 50% to 60% of primary immunodeficiencies; X-linked agammaglobulinemia (Bruton's) manifests after 6 months of age with profound pan-hypogammaglobulinemia and absent peripheral B cells (BTK mutation), whereas selective IgA deficiency can be associated with rare transfusion anaphylaxis; product selection depends particularly on any previous reaction.
Severe Combined Immunodeficiency (SCID) is a medical emergency requiring urgent diagnosis (screened by neonatal T-cell receptor excision circles [TREC]), protective isolation, irradiated leukodepleted blood products, antimicrobial prophylaxis, and curative hematopoietic stem cell transplantation; live attenuated vaccines are absolutely contraindicated.
DiGeorge syndrome (22q11.2 deletion syndrome, CATCH-22) combines conotruncal congenital heart defects, dysmorphic facies, thymic hypoplasia with variable T-cell deficiency, cleft palate, and neonatal hypocalcemia secondary to parathyroid hypoplasia.
Live attenuated vaccines (MMR, Varicella, BCG, Rotavirus, Oral Poliovirus, Yellow Fever) are strictly contraindicated in severe T-cell immunodeficiencies, active leukemia/lymphoma chemotherapy, and high-dose systemic corticosteroid therapy due to the catastrophic risk of disseminated, fatal vaccine-strain disease.
Last updated: November 2026
Inborn Errors of Immunity, Diagnostic Frameworks, and European Vaccination Protocols
Inborn Errors of Immunity (IEI)—historically termed Primary Immunodeficiency Disorders (PID) —comprise a heterogeneous spectrum of monogenic diseases impairing the development, differentiation, or function of the immune system. Early clinical recognition is essential: timely diagnosis prevents end-organ damage (e.g., bronchiectasis), allows curative hematopoietic cellular therapies, and prevents catastrophic iatrogenic complications such as fatal infections from live attenuated vaccines.
The Jeffrey Modell 10 Warning Signs of Primary Immunodeficiency
The Jeffrey Modell Foundation established 10 clinical warning signs to guide general pediatricians in identifying children requiring immediate immunological workup: THE JEFFREY MODELL 10 WARNING SIGNS OF PID
- 1. >= 4 New Ear Infections (Otitis Media) within 1 Year
- 2. >= 2 Serious Sinus Infections within 1 Year
- 3. >= 2 Months on Antibiotics with Little or No Clinical Benefit
- 4. >= 2 Pneumonias within 1 Year
- 5. Failure of an Infant to Gain Weight or Grow Normally (Failure to Thrive)
- 6. Recurrent, Deep Skin or Organ Abscesses (e.g., Hepatic, Perirectal)
- 7. Persistent Oral Thrush or Cutaneous Fungal Infection After Age 1 Year
- 8. Need for Intravenous Antibiotics to Clear Infections
- 9. >= 2 Deep-Seated Infections (Septicemia, Meningitis, Osteomyelitis)
- 10. A Positive Family History of Primary Immunodeficiency
Note
A child who fulfills two or more of the Jeffrey Modell warning signs warrants prompt formal immunological investigation, beginning with a complete blood count with differential, quantitative serum immunoglobulins (IgG, IgA, IgM, IgE), and functional vaccine antibody titers.
Classification and Pathophysiology of Primary Immunodeficiencies
Primary immunodeficiencies are classified into four major functional branches based on the component of the immune system affected:
Primary Defect Proportion Typical Onset Age Signature Pathogens Hallmark Clinical Presentations
B-Cell / Humoral Deficiencies 50%–60% After 6–9 months (as maternal IgG wanes) Encapsulated pyogenic bacteria ( S. pneumoniae , H. influenzae ), Giardia , enteroviruses Recurrent acute otitis media, sinopulmonary infections, bronchiectasis, absent lymph nodes/tonsils
T-Cell / Combined Deficiencies 15%–20% Early infancy (<3–6 months) Opportunistic pathogens: Pneumocystis jirovecii , CMV, EBV, Candida , mycobacteria Severe failure to thrive, persistent chronic diarrhea, refractory thrush, extensive interstitial pneumonitis
Phagocytic Disorders 10%–15% Variable (Infancy to early childhood) Catalase-positive organisms : S. aureus , Aspergillus , Serratia , Burkholderia , Nocardia Deep organ abscesses (liver/lung), suppurative lymphadenitis, delayed umbilical cord separation, absent pus
Complement Deficiencies 2%–5% Older childhood / Adolescence Encapsulated organisms, especially Neisseria meningitidis (MAC C5–C9) Recurrent invasive meningococcemia, systemic lupus erythematosus (C1/C4/C2), non-pruritic angioedema (C1-INH)
- Detailed Molecular and Clinical Subtypes
- 1. B-Cell / Antibody Deficiencies
X-Linked Agammaglobulinemia (XLA / Bruton's Disease) : Caused by loss-of-function mutations in the BTK gene on chromosome Xq22, encoding Bruton tyrosine kinase . BTK is an intracellular signaling molecule essential for the transition of pro-B cells to pre-B cells in the bone marrow. As a result, B-cell development is arrested.
Immunological Hallmarks : Complete absence or profound reduction of mature circulating B lymphocytes ( CD19+ and CD20+ B cells < 1 % – 2 % <1\%–2\% < 1%–2% ), accompanied by profound pan-hypogammaglobulinemia ( undetectable or markedly low IgG, IgA, IgM, and IgE ). Normal T-cell numbers (CD3+, CD4+, CD8+).
Clinical Presentation : Affected male infants become symptomatic around 6 to 9 months of age , coinciding with the physiological clearance of transplacentally acquired maternal IgG. They suffer recurrent, severe sinopulmonary bacterial infections ( S. pneumoniae , H. influenzae ), purulent conjunctivitis, skin infections, and enteroviral meningoencephalitis. On physical examination, tonsils and peripheral lymph nodes are absent or severely hypoplastic .
Management : Lifelong monthly intravenous immunoglobulin (IVIG) or weekly subcutaneous immunoglobulin (SCIG) replacement therapy. Live vaccines are strictly contraindicated .
Common Variable Immunodeficiency (CVID) : The most frequent clinically significant primary immunodeficiency presenting in older children, adolescents, and adults. Characterized by impaired terminal differentiation of B cells into functional antibody-secreting plasma cells.
Immunological Hallmarks : Normal or near-normal numbers of circulating B cells, but markedly decreased serum IgG (at least 2 SD below the age-adjusted mean) PLUS low IgA and/or IgM , combined with absent or defective antibody responses to protein (tetanus) or polysaccharide (pneumococcal) vaccines.
Clinical Features : Recurrent sinopulmonary infections leading to bronchiectasis; non-caseating granulomatous disease (liver, lungs); high prevalence of autoimmune cytopenias (immune thrombocytopenia [ITP], autoimmune hemolytic anemia [AIHA]); chronic enteropathy; and markedly increased risk of gastric adenocarcinoma and B-cell lymphoma.
Selective IgA Deficiency : The most common primary immunodeficiency overall (prevalence approximately 1 in 500 to 1 in 700 in European individuals). Defined as an undetectable serum IgA < 0.07 g/L \text{IgA} < 0.07\text{ g/L} IgA < 0.07 g/L with normal serum IgG and IgM levels in a child older than 4 years.
Clinical Relevance : Most patients are asymptomatic. Symptomatic individuals experience recurrent sinopulmonary infections, chronic giardiasis, atopic diseases, and autoimmune disorders (celiac disease, type 1 diabetes).
Transfusion Precautions : Anti-IgA antibodies may occur, but severe transfusion reactions are rare . With no previous reaction, standard components can be given with enhanced monitoring. After a prior transfusion reaction, consult transfusion medicine: elective transfusion may require washed red cells/platelets or IgA-deficient plasma . Do not delay life-saving transfusion if special components are unavailable; use standard components under direct monitoring with facilities to manage anaphylaxis.
- 2. T-Cell and Combined Immunodeficiencies [Combined Immunodeficiency Spectrum]
- |
- +--------------------------+--------------------------+
- | |
- [Severe Combined Immunodeficiency (SCID)] [DiGeorge Syndrome (22q11.2 Deletion)]
- Complete Absence of T-Cell Immunity - 3rd & 4th Pharyngeal Pouch Defect
- Low / Absent Neonatal TREC Screen - CATCH-22 Clinical Manifestations:
- Opportunistic Infections at 2-4 Months: * Cardiac: Truncus Arteriosus, IAA, TOF
- * Pneumocystis jirovecii Pneumonia (PJP) * Abnormal Facies (Micrognathia)
- * Cytomegalovirus (CMV), Intractable Thrush * Thymic Hypoplasia (Low T Cells)
- Fatal in Infancy Without HSCT * Cleft Palate / Hypernasal Speech
- Irradiated, Leukodepleted Blood Only * Hypocalcemia (Parathyroid Aplasia)
- STRICT BAN ON ALL LIVE VACCINES * Neonatal Tetany / Seizures
Severe Combined Immunodeficiency (SCID) : A pediatric medical emergency characterized by absent or non-functional T lymphocytes with variable absence of B and NK cells (e.g., T − B + N K − T^- B^+ NK^- T − B + N K − due to X-linked common gamma chain mutation IL2RG ; T − B − N K − T^- B^- NK^- T − B − N K − due to Adenosine Deaminase [ ADA ] deficiency; T − B − N K + T^- B^- NK^+ T − B − N K + due to RAG1/RAG2 mutations).
Newborn Screening : Quantifies T-cell receptor excision circles (TRECs) via real-time PCR on newborn dried blood spots. TRECs are stable circular DNA fragments produced during normal TCR rearrangement in the thymus; low or absent TRECs identifies SCID presymptomatically at birth.
Clinical Course : Infants present within the first 2 to 4 months of life with severe failure to thrive, chronic intractable diarrhea, persistent oral candidiasis, and life-threatening opportunistic infections, especially Pneumocystis jirovecii pneumonia (PJP) and Cytomegalovirus (CMV).
Mandatory Precautions :
Strict contraindication of all live vaccines (administration of rotavirus vaccine causes persistent fatal diarrhea; BCG causes lethal disseminated BCG-osis).
All blood products must be leukodepleted, irradiated (to prevent fatal Transfusion-Associated Graft-versus-Host Disease [TA-GvHD]), and CMV-seronegative .
Co-trimoxazole (trimethoprim-sulfamethoxazole) prophylaxis for PJP and regular IVIG while immunodeficient; reassess their continuation after definitive therapy and immune reconstitution.
Definitive curative therapy: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) or autologous gene therapy.
DiGeorge Syndrome (22q11.2 Deletion Syndrome) : Disruption of the embryonic development of the third and fourth pharyngeal pouches caused by a heterozygous microdeletion on chromosome 22q11.2. Remembered by the mnemonic CATCH-22 :
C - Cardiac defects : Conotruncal anomalies, including interrupted aortic arch (type B), truncus arteriosus, tetralogy of Fallot, and ventricular septal defect (VSD).
A - Abnormal facies : Hypertelorism, micrognathia, low-set malformed ears, short philtrum, and prominent nasal root with bulbous tip.
T - Thymic hypoplasia / aplasia : Defective T-cell maturation. Most children have 'partial DiGeorge' with mild-to-moderate T-cell lymphopenia that improves with age; fewer than 1% have 'complete DiGeorge' (athymic, presenting with a SCID phenotype requiring cultured thymus transplantation).
C - Cleft palate : Submucous cleft palate, bifid uvula, and velopharyngeal insufficiency causing hypernasal speech.
H - Hypocalcemia : Secondary to parathyroid gland hypoplasia , presenting in the neonatal period with hypocalcemic tetany, tremors, carpopedal spasm, or seizures.
3. Phagocytic Disorders
Chronic Granulomatous Disease (CGD) : Impairment of the phagocyte respiratory (oxidative) burst caused by mutations in the multicomponent NADPH oxidase enzyme complex (most commonly X-linked recessive mutations in CYBB encoding gp91phox [~70%], followed by autosomal recessive mutations in NCF1 [p47phox]). Phagocytes ingest bacteria normally but cannot synthesize reactive oxygen species (superoxide anion, hydrogen peroxide, hypochlorous acid) to kill internalized microbes.
The Catalase-Positive Vulnerability : Microorganisms produce small amounts of endogenous hydrogen peroxide as metabolic by-products. Most bacteria lack catalase, allowing the neutrophil to utilize the microbe's own hydrogen peroxide to effect killing. However, catalase-positive microorganisms produce the enzyme catalase, which degrades hydrogen peroxide ( 2 H 2 O 2 → 2 H 2 O + O 2 2\text{H}_2\text{O}_2 \rightarrow 2\text{H}_2\text{O} + \text{O}_2 2 H 2 O 2 → 2 H 2 O + O 2 ). Deprived of both host and microbial peroxides, CGD neutrophils cannot destroy these pathogens.
The Five Classic Pathogens : Staphylococcus aureus , Aspergillus species, Serratia marcescens , Burkholderia cepacia complex, and Nocardia species (alongside Salmonella ).
Clinical Hallmark : Recurrent suppurative lymphadenitis, hepatic and splenic abscesses, osteomyelitis ( Serratia ), pulmonary fungal granulomas, and chronic inflammatory granuloma formation obstructing the gastric outlet or urinary tract.
Diagnostic Test : Dihydrorhodamine 123 (DHR) flow cytometry assay . Neutrophils are stimulated ex vivo; oxidation of non-fluorescent DHR to brightly fluorescent rhodamine by intracellular hydrogen peroxide is quantified. CGD neutrophils exhibit complete failure of fluorescence shift. (Replaces the obsolete nitroblue tetrazolium / NBT test).
Management : Lifelong daily antibacterial prophylaxis with Co-trimoxazole , daily antifungal prophylaxis with Itraconazole , and subcutaneous Recombinant Interferon-gamma (IFN- γ \gamma γ ) ; definitive cure achieved via HSCT.
Leukocyte Adhesion Deficiency Type 1 (LAD-1) : Autosomal recessive defect in the ITGB2 gene encoding the CD18 beta-2 integrin subunit. Neutrophils cannot adhere to endothelial ICAM-1 and fail to extravasate from the bloodstream into infected peripheral tissues.
Clinical Triad : Delayed separation of the umbilical cord ( > 3 to 4 >3\text{ to }4 > 3 to 4 weeks of life) ; severe necrotic, ulcerating skin and mucous membrane infections that conspicuously lack pus formation (cold abscesses); and extreme, persistent peripheral leukocytosis / neutrophilia ( 20 , 000 to 100 , 000 / μ L 20,000\text{ to }100,000 /\mu\text{L} 20 , 000 to 100 , 000/ μ L ) even when clinically uninfected.
4. Complement Deficiencies
Terminal Complement Deficiencies (C5, C6, C7, C8, C9 / Membrane Attack Complex [MAC]) : Failure to assemble the lytic pore complex ( C 5 b – 9 C5b\text{–}9 C 5 b – 9 ). Clinically characterized by striking, recurrent, invasive meningococcal disease caused by Neisseria meningitidis , frequently involving uncommon serogroups (W-135, Y, X). Screened via the CH50 (total hemolytic complement) assay , which is zero or markedly depressed.
Hereditary Angioedema (HAE) : Autosomal dominant deficiency (Type I) or dysfunction (Type II) of C1 Esterase Inhibitor (C1-INH) . Unregulated kallikrein activation drives excessive production of bradykinin . Presents with recurrent, self-limiting episodes of non-pruritic, non-pitting subcutaneous angioedema, agonizing abdominal pain (bowel edema), and life-threatening laryngeal edema. Urticaria and pruritus are completely absent . Investigate suspected HAE with C1-INH function, C1-INH antigen level and serum C4 ; C4 alone is insufficient. Acute treatment utilizes C1-INH concentrate or Icatibant (bradykinin B2 receptor antagonist).
- Vaccination Protocols and Contraindicated Live Vaccines
- Live Attenuated versus Inactivated Vaccines
Vaccine Class Specific Pediatric Vaccines Mechanism of Action Safety in Immunodeficiency
Live Attenuated MMR , Varicella , BCG , Rotavirus , Yellow Fever , Oral Polio (OPV) , Intranasal Influenza (LAIV) Attenuated pathogen replicates in host to stimulate durable humoral and cellular immunity ABSOLUTELY CONTRAINDICATED in severe T-cell deficiencies, chemotherapy, and high-dose steroids
Inactivated / Subunit / Toxoid / Conjugate Hexavalent (DTaP-IPV-Hib-HepB), Pneumococcal (PCV13/15/20), MenACWY, MenB, Inactivated Influenza, HPV Non-replicating antigens, protein conjugates, or recombinant virus-like particles (VLP) SAFE to administer; antibody response may be blunted, but zero risk of viral replication
Absolute Contraindications to Live Vaccines in Children
Live vaccines are contraindicated during significant immunosuppression; reintroduction requires specialist assessment and the applicable national guidance. Important situations include:
Severe T-cell / Combined Immunodeficiencies : SCID, complete DiGeorge syndrome, severe ataxia-telangiectasia, Wiskott-Aldrich syndrome.
Malignancy and Active Chemotherapy : Leukemia, lymphoma, or solid tumors undergoing immunosuppressive cytotoxic therapy, and for at least 6 months following cessation of chemotherapy.
Systemic Corticosteroids : Apply the national rule. CDC uses prednisolone-equivalent ≥2 mg/kg/day or ≥20 mg/day if >10 kg for ≥14 days , followed by at least 1 month before live vaccines. UK Green Book excludes live vaccines for 3 months after >40 mg/day (2 mg/kg/day if <20 kg) for >1 week , or >20 mg/day (1 mg/kg/day if <20 kg) for >14 days .
Biological Immunosuppressive Therapy : Anti-TNF agents (infliximab, adalimumab) and B-cell depleting therapies (rituximab; defer live vaccines for 6–12 months).
Post-Hematopoietic Stem Cell Transplantation (HSCT) : Defer live vaccines for at least 24 months post-transplant , and only if the child is free of active Graft-versus-Host Disease (GvHD) and off all systemic immunosuppressive medications.
Warning
Administering the live BCG vaccine to an infant with unrecognized Severe Combined Immunodeficiency (SCID) or Chronic Granulomatous Disease results in fatal disseminated BCG-osis . Administering the live oral Rotavirus vaccine to an infant with SCID produces intractable, life-threatening viral enteritis and severe wasting.
European Routine Childhood Immunisation Architecture
European programmes share core vaccines, but dose timing and products follow each country's current schedule and birth-cohort rules; consult the national programme or ECDC Vaccine Scheduler:
Hexavalent Vaccine (DTaP-IPV-Hib-HepB) : Diphtheria, Tetanus, acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae type b capsular conjugate, and Hepatitis B surface antigen. Delivered according to standard European 2+1 schedules (2, 4, and 11–12 months) or 3+1 schedules (2, 3, 4, and 11–12 months).
Pneumococcal Conjugate Vaccines (PCV13 / PCV15 / PCV20) : These CRM197-conjugated products protect against invasive pneumococcal disease. Follow the national and product-specific schedule: EMA's Prevenar 20 infant regimen has three primary doses from 6 weeks of age plus a booster at 11–15 months ; a three-dose total series is not interchangeable across all products.
Meningococcal Vaccines : Recombinant protein MenB vaccine and quadrivalent conjugate MenACWY vaccine.
Measles-Containing Vaccine : Give two routine doses at nationally specified ages. Germany recommends MMR at 11 and 15 months ; England offers MMRV at 12 and 18 months for eligible birth cohorts from 2026. Catch-up and earlier outbreak/travel doses follow national guidance.
Human Papillomavirus (HPV) Vaccine : Recombinant L1 virus-like particle vaccines prevent HPV-associated cancers and genital warts. Vaccinate girls and boys before exposure using the national schedule: programmes may use one or two routine doses. England uses one dose at 12–13 years , with three doses for immunosuppressed or HIV-positive recipients .